Key statistics
As of last trade Rezolute Inc (6HV1:BER) traded at 3.34, -30.42% below its 52-week high of 4.80, set on May 22, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 0.00 |
---|---|
High | 3.34 |
Low | 3.34 |
Bid | -- |
Offer | -- |
Previous close | 3.34 |
Average volume | -- |
---|---|
Shares outstanding | 57.94m |
Free float | 50.26m |
P/E (TTM) | -- |
Market cap | 337.23m USD |
EPS (TTM) | -1.27 USD |
Data delayed at least 15 minutes, as of May 22 2024 13:10 BST.
More ▼
Announcements
- Rezolute Reports First Quarter Fiscal 2025 Financial Results and Provides Business Update
- Rezolute to Participate in Upcoming Investor Conferences
- Rezolute Reports Fourth Quarter and Full Year Fiscal 2024 Financial Results and Provides Business Update
- FDA Lifts Partial Clinical Holds on RZ358 for the Treatment of Congenital Hyperinsulinism and Authorizes U.S. Inclusion in Ongoing Phase 3 Study
- Rezolute Announces FDA Clearance of IND Application for Phase 3 Registrational Study of RZ358 for Treatment of Hypoglycemia Due to Tumor Hyperinsulinism
- Rezolute to Participate in the BTIG Virtual Biotechnology Conference
- Rezolute Announces Exercise of Underwriters’ Option to Purchase Additional Shares and Concurrent Private Placement
- Rezolute Announces Closing of Public Offering with Approximately $60M in Gross Proceeds
- Rezolute Announces Pricing of Public Offering of $60 Million of Common Stock and Pre-Funded Warrants
- Rezolute Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants
More ▼